Stevanato Group (NYSE:STVN) Given New $26.00 Price Target at Bank of America

Stevanato Group (NYSE:STVN) had its target price hoisted by investment analysts at Bank of America from $24.00 to $26.00 in a report issued on Friday,Benzinga reports. The firm presently has a “buy” rating on the stock.

Several other equities research analysts have also commented on the stock. Morgan Stanley reiterated an “equal weight” rating and issued a $23.00 price objective (down from $24.00) on shares of Stevanato Group in a research report on Tuesday, December 3rd. Wolfe Research began coverage on shares of Stevanato Group in a report on Friday. They issued an “outperform” rating and a $28.00 price target on the stock. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of €28.60 ($30.11).

Stevanato Group Stock Up 4.6 %

STVN traded up €1.04 ($1.09) during trading on Friday, reaching €23.51 ($24.75). The company’s stock had a trading volume of 409,477 shares, compared to its average volume of 500,231. The company’s fifty day moving average price is €19.58 and its 200-day moving average price is €19.65. Stevanato Group has a 52-week low of €16.56 ($17.43) and a 52-week high of €34.73 ($36.56). The company has a debt-to-equity ratio of 0.22, a current ratio of 1.81 and a quick ratio of 1.21.

Stevanato Group (NYSE:STVN) last issued its earnings results on Tuesday, November 5th. The company reported €0.12 ($0.13) EPS for the quarter, missing the consensus estimate of €0.13 ($0.14) by (€0.01) (($0.01)). The company had revenue of €277.90 million for the quarter, compared to analysts’ expectations of €274.36 million. Stevanato Group had a return on equity of 9.86% and a net margin of 10.47%. Stevanato Group’s revenue for the quarter was up 2.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.16 earnings per share. Research analysts forecast that Stevanato Group will post 0.5 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of STVN. nVerses Capital LLC bought a new stake in shares of Stevanato Group in the 3rd quarter worth approximately $84,000. Raymond James Trust N.A. increased its position in Stevanato Group by 18.7% in the second quarter. Raymond James Trust N.A. now owns 10,239 shares of the company’s stock worth $188,000 after buying an additional 1,613 shares during the period. Hardy Reed LLC lifted its stake in Stevanato Group by 8.2% in the third quarter. Hardy Reed LLC now owns 11,077 shares of the company’s stock valued at $222,000 after buying an additional 840 shares during the last quarter. Lindenwold Advisors INC grew its position in shares of Stevanato Group by 13.5% during the third quarter. Lindenwold Advisors INC now owns 11,930 shares of the company’s stock worth $239,000 after acquiring an additional 1,415 shares during the last quarter. Finally, Oppenheimer Asset Management Inc. increased its holdings in shares of Stevanato Group by 59.2% in the 2nd quarter. Oppenheimer Asset Management Inc. now owns 11,941 shares of the company’s stock worth $219,000 after acquiring an additional 4,441 shares during the period.

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.